1. Home
  2. CTKB vs DAVE Comparison

CTKB vs DAVE Comparison

Compare CTKB & DAVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTKB
  • DAVE
  • Stock Information
  • Founded
  • CTKB 1990
  • DAVE 2017
  • Country
  • CTKB United States
  • DAVE United States
  • Employees
  • CTKB N/A
  • DAVE N/A
  • Industry
  • CTKB Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • DAVE Retail: Computer Software & Peripheral Equipment
  • Sector
  • CTKB Health Care
  • DAVE Technology
  • Exchange
  • CTKB Nasdaq
  • DAVE Nasdaq
  • Market Cap
  • CTKB 708.8M
  • DAVE 795.6M
  • IPO Year
  • CTKB 2021
  • DAVE N/A
  • Fundamental
  • Price
  • CTKB $6.27
  • DAVE $87.84
  • Analyst Decision
  • CTKB Strong Buy
  • DAVE Strong Buy
  • Analyst Count
  • CTKB 3
  • DAVE 6
  • Target Price
  • CTKB $9.17
  • DAVE $96.50
  • AVG Volume (30 Days)
  • CTKB 646.8K
  • DAVE 533.9K
  • Earning Date
  • CTKB 11-05-2024
  • DAVE 11-12-2024
  • Dividend Yield
  • CTKB N/A
  • DAVE N/A
  • EPS Growth
  • CTKB N/A
  • DAVE N/A
  • EPS
  • CTKB N/A
  • DAVE 3.12
  • Revenue
  • CTKB $201,210,000.00
  • DAVE $319,355,000.00
  • Revenue This Year
  • CTKB $8.18
  • DAVE $30.69
  • Revenue Next Year
  • CTKB $13.21
  • DAVE $20.47
  • P/E Ratio
  • CTKB N/A
  • DAVE $28.17
  • Revenue Growth
  • CTKB 9.88
  • DAVE 30.00
  • 52 Week Low
  • CTKB $4.66
  • DAVE $7.73
  • 52 Week High
  • CTKB $9.87
  • DAVE $108.50
  • Technical
  • Relative Strength Index (RSI)
  • CTKB 45.80
  • DAVE 53.74
  • Support Level
  • CTKB $6.11
  • DAVE $82.18
  • Resistance Level
  • CTKB $6.78
  • DAVE $108.50
  • Average True Range (ATR)
  • CTKB 0.33
  • DAVE 9.09
  • MACD
  • CTKB -0.09
  • DAVE -1.69
  • Stochastic Oscillator
  • CTKB 13.95
  • DAVE 26.92

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

About DAVE Dave Inc.

Dave Inc is a financial services company. It is engaged in offering banking app that offers its customers banking, financial insights, overdraft protection, building credit, and finding side gigs.

Share on Social Networks: